Skip to main content
SpringerLink
Log in

Endogenous antigen presentation by MHC class II molecules

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

T cell recognition of antigen requires that a complex form between peptides derived from the protein antigen and cell surface glycoproteins encoded by genes within the major histocompatibility complex (MHC). MHC class II molecules present both extracellular (exogenous) and internally synthesized (endogenous) antigens to the CD4 T cell subset of lymphocytes. The mechanisms of endogenous antigen presentation are the subject of this review. Isolation and amino acid sequencing of peptides bound to the class II molecule indicate that a very high proportion (70–90%) of the total peptides presented by the class II molecule are in fact derived from the pool of proteins that are synthetized within the antigen-presenting cell (APC). This type of sequence information as well as the study of model antigens has indicated that proteins expressed in a diversity of intracellular sites, including the cell surface, endoplasmic reticulum and cytosol can gain access to the class II molecule, albeit with different efficiencies. The main questions that remain to be answered are the intracellular trafficking patterns that allow colocalization of internally synthesized antigens with the class II molecule, the site(s) within the cell where peptide: class II molecule complex formation can take place and whether presentation of ‘foreign’ as well as ‘self’ antigens takes place by mechanisms that vary from one cell type to another or that vary with the metabolic state of the APC. If such variability exists, is would imply that the array of peptides displayed by class II molecules at the cell surface has similar variability, a possibility that would impact on self tolerance and autoimmunity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bjorkman P, Saper M, Samraoui B, Bennet W, Strominger J, Wiley D: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512–518.

    Article  PubMed  CAS  Google Scholar 

  2. Blackwell J, Roberts M: Immunomodulation of murine visceral leishmaniasis by administration of monoclonal anti-I-A antibodies: Differential effects of anti-I-A vs anti-I-E antibodies. Eur J Immunol 1987;17:1669–1672.

    Article  PubMed  CAS  Google Scholar 

  3. Stern L, Wiley D: The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 1992;68:465–477.

    Article  PubMed  CAS  Google Scholar 

  4. Brown J, Jardetzky T, Goga J, Stern L, Urban R, Strominger J, Wiley D: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33–39.

    Article  PubMed  CAS  Google Scholar 

  5. Germain RN: The ins and outs of antigen processing and presentation. Nature (London) 1986;322:687–688.

    Article  CAS  Google Scholar 

  6. Morrison L, Lukacher A, Braciale V, Fan D, Braciale T: Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med 1986;163:903–921.

    Article  PubMed  CAS  Google Scholar 

  7. Monaco J: A molecular model of MHC class I-restricted antigen processing. Immunol Today 1992;13:173–179.

    Article  PubMed  CAS  Google Scholar 

  8. Attaya M, Jameson S, Martinez C, Hermel E, Aldrich C, Forman J, Lindahl K, Bevan M, Monaco J: Ham-2 corrects the class I antigen processing defect in RMA-S cells. Nature (London) 1992;355:647–649.

    Article  CAS  Google Scholar 

  9. Deverson E, Gow I, Coadwell W, Monaco J, Butcher G, Howard J: MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 1990;348:738–741.

    Article  PubMed  CAS  Google Scholar 

  10. Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990;348:744–747.

    Article  PubMed  CAS  Google Scholar 

  11. Powis S, Townsend A, Deverson E, Bastin J, Butcher G, Howard J: Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 1991;354:528–531.

    Article  PubMed  CAS  Google Scholar 

  12. Kozlowski S, Takeshita T, Boencke W.-H., Takahashi H, Boyd L, Germain R, Berzofsky J, Margulies D: Excess β2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature 1991;349:74–77.

    Article  PubMed  CAS  Google Scholar 

  13. Ribaudo R, Margulies D: Independent and synergistic effects of disulfide bond formation, beta 2 micro-globulin, and peptides on class I MHC folding and assembly in an in vitro translation system. J Immunol 1992;149:2935–2944.

    PubMed  CAS  Google Scholar 

  14. Degen E, Williams D: Participation of a novel 88-kD protein in the biogenesis of murine class I histocompatibility molecules. J Cell Biol 1991;112:1099–1115.

    Article  PubMed  CAS  Google Scholar 

  15. Ahluvalia N, Bergeron JJM, Wada I, Degan E, Williams D: The p88 molecular chaperone is identical to the endoplasmic reticulum membrane protein, calnexin. J Biol Chem 1992;267:10914–10918.

    Google Scholar 

  16. Townsend A, Ohlen C, Bastin J, Ljunggren J, Foster L, Karrer K: Associaton of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989;340:443–448.

    Article  PubMed  CAS  Google Scholar 

  17. Ljunggren H, Stam N, Ohlen C, Neefjes J, Hoglund P, Heemels M, Bastin J, Schumacher T, Townsend A, Karre K, Ploegh H: Empty MHC class I molecules come out in the cold. Nature 1990;346:476–480.

    Article  PubMed  CAS  Google Scholar 

  18. Neefjes J, Stollorz V, Peters P, Geuze H, Ploegh H: The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 1990;61:171–183.

    Article  PubMed  CAS  Google Scholar 

  19. Cresswell P: Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor mediated endocytosis. Proc Natl Acad Sci USA 1985;82:8188–8192.

    Article  PubMed  CAS  Google Scholar 

  20. Amigorena S, Drake J, Webster P, Mellman I: Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 1994;369:113–126.

    Article  PubMed  CAS  Google Scholar 

  21. Qiu Y, Xu X, Wandinger-Ness A, Dalke DP, Pierce SK: Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol 1994;125:595–605.

    Article  PubMed  CAS  Google Scholar 

  22. Tulp A, Verwoerd D, Dobberstein B, Ploegh H.B, Pieters J: Isolation and characterization of the intracellular MHC class II compartment. Nature 1994;369:120–126.

    Article  PubMed  CAS  Google Scholar 

  23. Roche P, Cresswell P: Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci USA 1991;88:3150–3154.

    Article  PubMed  CAS  Google Scholar 

  24. Roche P, Cresswell P: Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 1990;345:615–618.

    Article  PubMed  CAS  Google Scholar 

  25. Weiss S, Bogen B: B lymphoma cells process and present their endogenous Ig to MHC restricted T cells. Proc Natl Acad Sci USA 1989;86:282–286.

    Article  PubMed  CAS  Google Scholar 

  26. Weiss S, Boen B: MHC class II restricted presentation of intracellular antigen. Cell 1991;64:767–776.

    Article  PubMed  CAS  Google Scholar 

  27. Nuchtern J, Biddison W, Klausner R: Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990;343:74–76.

    Article  PubMed  CAS  Google Scholar 

  28. Bikoff EK: Class II restricted IgG2ab-specific T cells recognize a signal minus form of the V-CH3b antigen. Eur J Immunol 1991;21:1411–1417.

    Article  PubMed  CAS  Google Scholar 

  29. Bikoff E: Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous proteins antigens. J Immunol 1992;149:1–8.

    PubMed  CAS  Google Scholar 

  30. Brooks A, Hartley S, Kjer-Nielsen L, Perara J, Goodnow C, Basten A, McCluskey J: Class II-restricted presentation of an endogenously derived immunodominant T cell determinant of hen egg lysozyme. Proc Natl Acad Sci USA 1991;88:3290–3294.

    Article  PubMed  CAS  Google Scholar 

  31. Chen B, Madrigal A, Parham P: Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med 1990;172:779–788.

    Article  PubMed  CAS  Google Scholar 

  32. Jaraquemad D, Marti M Long EO: An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J Exp Med 1990;172:947–954.

    Article  Google Scholar 

  33. Loss GE, Elias CE, Fields PE, Ribaudo RK, McKisic M, Sant AJ: MHC class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I antigen presentation pathways. J Exp Med 1993;178:73–85.

    Article  PubMed  CAS  Google Scholar 

  34. Rudensky A, Preston-Hurlburt P, Hong S-C, Barlow A, Janeway CA: Sequence analysis of peptides bound to MHC class II molecules. Nature 1991;353:622–627.

    Article  PubMed  CAS  Google Scholar 

  35. Hunt D, Henderson R, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox A, Appella E, Engelhard V: Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992;255:1261–1263.

    Article  PubMed  CAS  Google Scholar 

  36. Lanzavecchia A: Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990;8:773.

    PubMed  CAS  Google Scholar 

  37. Castan LA, Pierce SK: Receptor mediated B cell antigen processing: Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J Immunol 1988;140:404–415.

    Google Scholar 

  38. Buus S, Sette A, Colon S, Grey H: Autologous peptides consistutively occupy the antigen binding site on Ia. Science 1988;242:1045–1047.

    Article  PubMed  CAS  Google Scholar 

  39. Babbitt, B, Allen P, Matsueda G, Haber E, Unanue E: The binding of immunogenic peptides to Ia histocompatibility molecules. Nature 1985;317:359–361.

    Article  PubMed  CAS  Google Scholar 

  40. Buus S, Sette A, Colon S, Jenis D, Grey H: Isolation and characterization of antigen-Ia complexes in T cell recognition. Cell 1986;47:1071–1077.

    Article  PubMed  CAS  Google Scholar 

  41. Watts T, McConnell H: High affinity fluorescent peptide binding to I-Ad in lipid membranes. Proc Natl Acad Sci USA 1986;83:9660–9664.

    Article  PubMed  CAS  Google Scholar 

  42. Lanzavecchia A, Reid P, Watts C: Irreversible association of peptides with class II MHC molecules in living cells. Nature 1992;357:249–252.

    Article  PubMed  CAS  Google Scholar 

  43. Jensen PE: Long-lived complexes between peptide and class II major histocompatibility complexes are formed at low pH with no requirement for pH neutralization. J Exp Med 1992;176:793–798.

    Article  PubMed  CAS  Google Scholar 

  44. Hunt D, Michel H, Dickinson T, Shabanowitz J, Cox A, Sakaguchi K, Appella E, Grey H, Sette A: Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 1992;256:1817–1820.

    Article  PubMed  CAS  Google Scholar 

  45. Chicz R, Urban R, Lane W, Gorga J, Stern L, Vignali D, Strominger J: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature 1992;358:764–768.

    Article  PubMed  CAS  Google Scholar 

  46. Chicz RM, Urban RG, Gorga JG, Vignali DAA, Lane WS, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993;178:27–47.

    Article  PubMed  CAS  Google Scholar 

  47. Engelhard VH: Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 1994;6:13–23.

    Article  PubMed  CAS  Google Scholar 

  48. Catipovic B, Dal-Porto J, Mage M, Johansen T, Schneck J: Major histocompatibility complex conformational epitopes are peptide specific. J Exp Med 1992;176:1611–1618.

    Article  PubMed  CAS  Google Scholar 

  49. Bluestone J, Jameson S, Miller S. Dick R: Peptide induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J Exp Med 1992;176:1757–1761.

    Article  PubMed  CAS  Google Scholar 

  50. Fremont D, Matsumara M, Stura E, Peterson P, Wilson I: Crystal structures of two viral peptides in complex with murine MHC class I H-2kb. Science 192;257:919–927.

  51. Thomas DB, Hodgson J, Riska PF, Graham CM: The role of the endoplasmic reticulum in antigen processing: N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processes antigen. J Immunol 1990;144:2789.

    PubMed  CAS  Google Scholar 

  52. Calin-Laurens V, Forquet F, Lonmabrd-Plate S, Bertolino P, Chretine I, Trescol-Biemont M, Gerlier D, Rabourdin-Combe C: High efficiency of endogenous antigen presentation by MHC class II molecules. Int Immunol 1992;4:1113–1121.

    Article  PubMed  CAS  Google Scholar 

  53. Chottanapund K, Sant AJ: Early biosynthetic forms of H-2Ld gain access to the MHC class II molecule. In preparation 1994.

  54. Calin-Laurens V, Forquet F, Mottez E, Kanellopoulos J, Godeau F, Kourilsky P, Gerlier D, Rabourdin-Combe C: Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol 1992;21:761–769.

    Article  Google Scholar 

  55. Brooks A, McCluskey J: Class II-restricted presentation of a hen egg lysozyme determinant from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. J Immunol 1993;150:3690–3697.

    PubMed  CAS  Google Scholar 

  56. Brown M, Driscoll J, Monaco J: Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 1991;353:355–357.

    Article  PubMed  CAS  Google Scholar 

  57. Patel S, Monaco J, McDevitt H: Delineation of the subunit composition of human proteasomes using antisera against the major histocompatibility complex encoded LMP2 and LMP7 subunits. Proc Natl Acad Sci USA 1994;91:296–300.

    Article  PubMed  CAS  Google Scholar 

  58. Lippincott-Schwartz J, Bonifacino J, Yuan L, Klausner R: Degradation from the endoplasmic reticulum: Disposing of newly synthesized proteins. Cell 1988;54:209–220.

    Article  PubMed  CAS  Google Scholar 

  59. Stafford FJ, Bonfacino JS: A permeabilized cell system identifies the endoplasmic reticulum as a site of protein degradation. J Cell Biol 1991;115:1225–1236.

    Article  PubMed  CAS  Google Scholar 

  60. Ziegler HK, Unanue ER: Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA 1982;79:175–178.

    Article  PubMed  CAS  Google Scholar 

  61. Nuchtern J, Bonifacino J, Biddison W, Klausner R: Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 1989;339:223–226.

    Article  PubMed  CAS  Google Scholar 

  62. Klausner RD, Donaldson JG, Lippincott-Schwartz J: Brefeldin A: Insights into the control of membrane traffic and organelle structure. J Cell Biol 1992;116:1071–1080.

    Article  PubMed  CAS  Google Scholar 

  63. Kreis A: Regulation of vesicular and tubular membrane traffic of the Golgi complex by coat proteins. Curr Opin Cell Biol 1992;4:609–615.

    Article  PubMed  CAS  Google Scholar 

  64. Harding C, Roof R, Allen P, Unanue E: Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci USA 1991;88:2740–2744.

    Article  PubMed  CAS  Google Scholar 

  65. Jensen P: Regulation of antigen presentation by acidic pH. J Exp Med 1990;171:1779–1784.

    Article  PubMed  CAS  Google Scholar 

  66. Wettstein D, Boniface J, Reay P, Schild H, Davis M: Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med 1991;174:219–228.

    Article  PubMed  CAS  Google Scholar 

  67. Teyton L, O'Sullivan D, Dickson P, Lotteau V, Sette A, Fink P, Peterson P: Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 1990;348:39–44.

    Article  PubMed  CAS  Google Scholar 

  68. Neefjes J, Ploegh H: Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J 1992;11:411–416.

    PubMed  CAS  Google Scholar 

  69. Loss GE, Sant AJ: Invariant chain retains MHC class II molecules in the endocytic pathway. J Immunol 1993;150:3187–3197.

    PubMed  CAS  Google Scholar 

  70. Seglen PO: Inhibitors of lysosomal function. Methods Enzymol 1983;96:737–765.

    Article  PubMed  CAS  Google Scholar 

  71. Seglen PO, Bohley P: Autophagy and other vacuolar protein degradation mechanisms. Experientia 1992;48:158–172.

    Article  PubMed  CAS  Google Scholar 

  72. Malnati M, Marti M, LaVaute T, Jaraquemada D, Biddison W, De-Mars R, Long E: Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 1992;357:702–704.

    Article  PubMed  CAS  Google Scholar 

  73. Sekaly R, Jacobsen S, Richert J, Tonnelle C, McFarland H, Long E: Antigen presentation to HLA class II-restricted measles virus-specific T cell clones can occur in the absence of the invariant chain. Proc Natl Acad Sci USA 1988;85:1209–1213.

    Article  PubMed  CAS  Google Scholar 

  74. Chervonsky AC., Gordon L, Sant AJ: MHC class II β chain express a targeting signal that directs localization of class II within the endocytic pathway. Int Immunol 1994;6:973–982.

    Article  PubMed  CAS  Google Scholar 

  75. Bijlmaker MJ, Benaroch P, Ploegh H: Assembly of HLA-DR molecules translated in vitro: Binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J 1994;13:2629–2707.

    Google Scholar 

  76. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequence encoded in the class II region of the MHC related to the ‘ABC’ superfamily of transporters. Nature 1990;348:741–744.

    Article  PubMed  CAS  Google Scholar 

  77. Germain R, Hendrix L: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 1991;353:134–139.

    Article  PubMed  CAS  Google Scholar 

  78. Sadegh-Nasseri S, Germain RN: A role for peptide in determining MHC class II structure. Nature 1991;353:167–170.

    Article  PubMed  CAS  Google Scholar 

  79. Dunn WA: Studies on the mechanisms of autophagy: Formation of the autophagic vacuole. J Cell Biol 1990;110:1923–1935.

    Article  PubMed  Google Scholar 

  80. Chaing H, Terlecky S, Plant CP, Dice J: A role for a 70 kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989;246:382–385.

    Article  Google Scholar 

  81. Dice J: Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 1990;15:305–309.

    Article  PubMed  CAS  Google Scholar 

  82. Sant AJ, Miller J: MHC class II antigen processing: Biology of invariant chain. Curr Opin Immunol 1994;6: 57.

    Article  PubMed  CAS  Google Scholar 

  83. Humbert M, Bertolineo P, Forquet F, Rabourdin-Combe C, Gerlier D, Davoust J, Salamero J: Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Eur J Immunol 1993;23:3167–3172.

    Article  PubMed  CAS  Google Scholar 

  84. Bodmer H, Viville S, Benoist C, Mathis D: Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 1994;2263:1284–1286.

    Article  Google Scholar 

  85. Long E.O, Lavaute T, Pinet V, Jaraquemada D: Invariant chain prevents HLA-DR-restricted presentation of a cytosolic peptide. J Immunol 1994;153:1487–1494.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Committee on Immunology, University of Chicago, 5841 S. Maryland Avenue MC1089, 60637, Chicago, IL, (USA)

    Andrea J. Sant

Authors
  1. Andrea J. Sant
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sant, A.J. Endogenous antigen presentation by MHC class II molecules. Immunol Res 13, 253–267 (1994). https://doi.org/10.1007/BF02935617

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02935617

Key Words

Search

Navigation